NEXT Biometrics Presents Fingerprint Sensor Technology & NEXT-generated Cards at APSCA in Singapore
Oct 31, 2017 23:17 pm UTC| Business
SINGAPORE, Oct. 31, 2017 -- NEXT Biometrics Group ASA (Oslo Bors:NEXT) announced it is exhibiting at this week’s Asia Pacific SmartCard Association (APSCA) Powered and Next-Generation Cards Conference Exhibition, held...
Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017
Oct 31, 2017 23:15 pm UTC| Business
SYDNEY, Australia, Oct. 31, 2017 -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer and Medical Officer, gave an oral presentation at the World...
KVH Launches New High-speed Maritime Network on Intelsat Epic(NG) Satellites
Oct 31, 2017 23:00 pm UTC| Business
MIDDLETOWN, R.I. and LUXEMBOURG, Oct. 31, 2017 -- KVH Industries, Inc., (Nasdaq:KVHI), today announced the launch of its next-generation, advanced maritime broadband network, joined by service partner, Intelsat S.A....
Oct 31, 2017 23:00 pm UTC| Business
MIDDLETOWN, R.I., Oct. 31, 2017 -- An advanced, 60 cm marine satellite antenna system designed to consistently deliver the fastest data speeds globally to the maritime market will be unveiled tomorrow by KVH Industries,...
Constellium prices offering of ordinary shares
Oct 31, 2017 22:49 pm UTC| Business
AMSTERDAM, The Netherlands, Oct. 31, 2017 -- Constellium N.V. (NYSE:CSTM) (Euronext Paris:CSTM) (“Constellium”) announced today that it has priced a public offering of 25,000,000 newly issued Class A ordinary shares...
Global Ship Lease Closes Notes Offering and Related Refinancing Transactions
Oct 31, 2017 22:40 pm UTC| Business
LONDON, Oct. 31, 2017 -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”) announced today that it has closed its previously announced offering (the “Offering”) of $360,000,000 aggregate principal amount of 9.875%...
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 31, 2017 22:30 pm UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare...
How the US–India tariff truce boosts major Indian industries, Surat to Pharma